Sarah Schram

Item: Sarah Schram
Rating: 2.91
Author: StockAnalysis.com

Stock Analyst at William Blair

(2.91)

# 1,539

Out of 4,900 analysts

Total ratings

50%

Success rate

109.83%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sarah Schram

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Initiates: Outperform	n/a	$14.70	-	1	Jan 3, 2025
	VIGL Vigil Neuroscience	Initiates: Outperform	n/a	$8.07	-	1	Dec 4, 2024

Denali Therapeutics

Jan 3, 2025

Initiates: Outperform

Price Target: n/a

Current: $14.70

Upside: -

Vigil Neuroscience

Dec 4, 2024

Initiates: Outperform

Price Target: n/a

Current: $8.07

Upside: -